CancerNetwork Members: Login | Register
 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Vol. 19 No. 1
Pages: 1  2  3  4  
Next
News & Analysis 

Without randomized trials, role of vitamin D in cancer prevention remains uncertain

By Fran Lowry | January 21, 2010

Does vitamin D have a role to play in preventing cancer, and if it does, what is the optimal dose? At the 2009 American Society of Preventive Oncology meeting in Tampa, Fla., investigators presented data about vitamin D and cancer, with conflicting results: While some studies have indicated that vitamin D can lower risk, others have deduced that vitamin D may have no effect as a preventative or, even worse, may boost cancer risk. In the end, the experts agreed that only large, prospective, randomized trials will off er definitive answers.

Lowering risk

There is a substantial body of data to support the idea that vitamin D supplementation may prevent cancer, said Donald L. Trump, MD, professor of oncology at Roswell Park Cancer Institute in Buffalo, N.Y. Because the exact role of vitamin D in cancer and human health is unclear, and links are almost all associational, the subject needs to be scrutinized in rigorous randomized trials.

Many epidemiologic studies show an association between low vitamin D levels and increased cancer risk and mortality, he said. "One study, by Carol Hanchette, PhD, and Gary Schwartz, PhD, found that the geographic distributions of ultraviolet radiation and prostate cancer mortality were inversely correlated, with significantly lower rates of prostate cancer in the southern part of the United States compared to the north. Another study by Professor Nicholas J. Rukin and colleagues made a similar association," he said (Cancer Causes Control 17:1091-1101, 2006; Br J Cancer 96:523- 528, 2007).

Dr. Trump has explored whether low vitamin D levels could be a risk factor for prostate cancer. He measured vitamin D levels in 100 patients with recurrent prostate cancer and in controls. However, both patients and controls had similarly low levels of vitamin D, leading him to conclude that the low vitamin D levels were a reflection of Buffalo's geography and not a characteristic unique to cancer patients.

"Still, there are lots of other cities in North America at this latitude, so if this latitude is a risk factor for cancer, there are many other cities and large-population areas that are at the same risk," he said.

Pages: 1  2  3  4  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 


 
FROM PHYSICIANS PRACTICE
'What They Should Really Teach in Medical School'
Julie Schopps, MD , February 6, 2012
The North Carolina-based pediatrician weighs in on why she thinks the real learning doesn't take place until students are out of the classroom.
Improve EHR Systems by Rethinking Medical Billing
Daniel Essin, MA, MD, February 6, 2012
Separating billing-related data from other clinical documentation and transmitting it to a billing system is not difficult …no matter how the charting is done.
Keeping Your Medical Practice’s Accounts Receivable on Track
P.J. Cloud-Moulds, February 4, 2012
Here are the minimum reports you should be running to keep an eye on your practices A/R.
Healthcare Providers Play Crucial Role in Helping Victims of Abuse
Stephen Hanson, PA-C , February 3, 2012
I would urge each and every one of you to be familiar with the warning signs of abuse, and the resources available to you all as healthcare providers.
Protecting Your Medical Practice's Data
Marisa Torrieri, February 3, 2012
Here's the scoop on how to implement a good data-backup plan at your office.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Management of Brain Metastases: Neurosurgical Considerations
  • Head and Neck Tumors
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • Younger Breast Cancer Patients Have More Adverse Quality of Life Issues
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • New Way to Predict Prostate Cancer Severity—Size of Prostate
  • AL Amyloidosis: Who, What, When, Why, and Where
  • The Maze of PARP Inhibitors in Ovarian Cancer
  • The Circuitous Path of PARP Inhibitor Development in Epithelial Ovarian Cancer
  • Podcast: Dr. David Ahlquist on Advances in Colorectal Cancer Screening
  • Lung Cancer Screening: A New Era
Click here to subscribe to our newsletter


CancerNetwork on Facebook

 


CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy